Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Lymphoid 3Breast 3Sarcoma 2Other hematologic neoplasm 2Head & Neck 2Genitourinary 2Other solid neoplasm 1Other neoplasm 1Myeloid 1Dermatologic 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Lymphoma 1HTLV-I Infections 1

Interventions

Oxycodone 2tremelimumab 1penpulimab 1peginterferon alfa-2b 1Zoledronic Acid 1Zidovudine 1Whole-Body Irradiation 1Valproic Acid 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1Sodium Chloride 1Selenium 1Rosuvastatin Calcium 1Rituximab 1Ribavirin 1Radiosurgery 1Proflavine 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Observation 1Moxifloxacin 1Morphine 1Microarray Analysis 1Methotrexate 1Methadone 1Laser Therapy 1Interferon alpha-2 1Infliximab 1Gene Expression Profiling 1Gadolinium DTPA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Valproic Acid × Other neoplasm × Clear all
NCT00854581 2018-04-17

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

University of Miami

Phase 4 Terminated
13 enrolled 15 charts
LymphoidOther hematologic neoplasmOther neoplasm

Lymphoma, Precancerous Conditions, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡